Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses.
Vaccine. 2011 May 17;29(22):3842-9. doi: 10.1016/j.vaccine.2011.02.067. Epub 2011 Mar 5.
Vaccine. 2011.
PMID: 21382484
Review.